Results 241 to 250 of about 26,997,198 (419)

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

Nature Network Boston, 2019
J. Rodón, J. Soria, R. Berger, Wilson H. Miller, E. Rubin, A. Kugel, A. Tsimberidou, P. Saintigny, A. Ackerstein, I. Braña, Y. Loriot, M. Afshar, V. Miller, F. Wunder, C. Bresson, J. Martini, J. Raynaud, J. Mendelsohn, G. Batist, A. Onn, J. Tabernero, R. Schilsky, V. Lazar, J. Lee, R. Kurzrock   +24 more
semanticscholar   +1 more source

Outcomes of Glenoid Labral Repair Using All-Suture Anchors. [PDF]

Orthop J Sports Med
Loeb AE, Moore Z, Ithurburn MP, Kidwell-Chandler AL, Atkinson A, Froom R, Mussell EA, Arceo C, Nguyen C, King E, Shepherd A, Beam J, Nodjomian J, Rothermich MA, Ryan MK, Emblom BA, Cain EL, Dugas JR.   +17 more
europepmc   +1 more source

Conservation medicine: combining the best of all worlds.

, 2003
Bob Weinhold
openalex   +1 more source

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

Molecular Oncology, EarlyView.
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Yan Li, Chunlin Zhou, Dong Lin, Min Wang, Hui Wei, Jianxiang Wang, Tao Cheng, Yingchang Mi   +13 more
wiley   +1 more source

Disaster medicine in Swedish undergraduate medical education: analysing current programs and future integration in the six-year curriculum. [PDF]

BMC Med Educ
Olsson S, Kurland L, Taube F, Björås J, Robinson Y.   +4 more
europepmc   +1 more source

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi, Kyle T. Helzer, Matthew L. Bootsma, Viridiana Carreno, Alex H. Chang, Luke A. Nunamaker, Grace C. Blitzer, Tianfu Andy Shang, Aishwarya Subramanian, Anders Bjartell, Andreas Josefsson, Pernilla Wikström, Emily Feng, Manish Kohli, Rendong Yang, Scott M. Dehm, Eric J. Small, Rahul Aggarwal, David A. Quigley, Joshua M. Lang, Shuang G. Zhao, Martin Sjöström   +26 more
wiley   +1 more source

Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts

Journal of Ethnopharmacology, 2021
Zhonglei Wang, Liyan Yang
semanticscholar   +1 more source

Are quality medicines affordable? Evidence from a large survey of medicine price and quality in Indonesia. [PDF]

BMJ Glob Health
Maria V, Tjandrawidjaya WN, Rahmawati A, Sarnianto P, Anggriani Y, Pisani E.   +5 more
europepmc   +1 more source

TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis

Molecular Oncology, EarlyView.
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam, Megan E. Roche, Zhao Lin, Diana Whitaker‐Menezes, Victor Diaz‐Barros, Eurico Serrano, Maria Paula Martinez Cantarin, Nancy J. Philp, Atrayee Basu Mallick, Ubaldo Martinez‐Outschoorn   +9 more
wiley   +1 more source